RekrutujeFaza III
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic…
Miasta: Białystok, Gdynia, Jasło, Katowice i 14 innych miastWiek: od 18 latSponsor: Astrazeneca AB
RekrutujeFaza III
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Miasta: Białystok, Kraków, Miechów, Opole i 7 innych miastWiek: od 18 latSponsor: Cytokinetics Inc.
RekrutujeFaza II/III
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Miasta: Białystok, Bydgoszcz, Gdańsk, Gliwice i 11 innych miastWiek: od 18 latSponsor: BioNTech SE
RekrutujeFaza III
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Miasta: Białystok, Gdańsk, Katowice, Konin i 9 innych miastWiek: od 18 latSponsor: BioNTech SE
RekrutujeFaza II
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Miasta: Białystok, Katowice, Lublin, Olsztyn i 10 innych miastWiek: od 18 latSponsor: Novo Nordisk A/S
RekrutujeFaza II/III
Ruxolitinib for childhood ALL in Poland (Rux-cALL-Pol 2020 trial) - Single-arm interventional study with ruxolitinib and AIEOP-BFM 2017 Poland or AIEOP-BFM 2017 standard of care…
Miasta: Białystok, Bydgoszcz, Gdańsk, Katowice i 11 innych miastWiek: do 17.99 latSponsor: Medical University Of Lodz
RekrutujeFaza III
Early rituximab treatment in children with idiopathic nephrotic syndrome Eng. ERICONS - Early RITUXIMAB in Childhood Onset Nephrotic Syndrome
Miasta: Białystok, Gdańsk, Kraków, Lublin i 5 innych miastWiek: do 17.99 latSponsor: Medical University Of Gdansk
RekrutujeFaza III
A clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma
Miasta: Białystok, Bydgoszcz, Gdańsk, Katowice i 9 innych miastWiek: do 64 latSponsor: Medical University Of Gdansk
RekrutujeFaza III
International phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy…
Miasta: Białystok, Bydgoszcz, Gdańsk, Katowice i 11 innych miastWiek: do 64 latSponsor: Universita Degli Studi Di Milano Bicocca
RekrutujeFaza III
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Miasta: Białystok, Gdańsk, Kielce, Kraków i 5 innych miastWiek: od 18 latSponsor: Merck Sharp & Dohme LLC
RekrutujeFaza III
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Miasta: Białystok, Bydgoszcz, Gdańsk, WarszawaWiek: od 18 latSponsor: Cybin IRL Limited
RekrutujeFaza III
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Miasta: Białystok, Gdańsk, ŁódźWiek: do 17.99 latSponsor: Novartis Pharma AG
RekrutujeFaza I
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
Miasta: Białystok, Bydgoszcz, Kraków, Poznań i 2 inne miastaWiek: od 18 latSponsor: Glaxosmithkline Research & Development Limited i jeszcze 1
RekrutujeFaza II
Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody
Miasta: Białystok, Gdańsk, Katowice, Lublin i 6 innych miastWiek: do 17.99 latSponsor: Poltreg S.A.
RekrutujeFaza III
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC)…
Miasta: Białystok, Kielce, Otwock, Poznań i 3 inne miastaWiek: od 18 latSponsor: Bayer AG
RekrutujeFaza III
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Miasta: Białystok, Bydgoszcz, Chojnice, Częstochowa i 27 innych miastWiek: od 18 latSponsor: Boehringer Ingelheim International GmbH
RekrutujeFaza II
Assessment of the safety and effectiveness of vedolizumab induction therapy compared to standard infliximab therapy in pediatric patients with ulcerative colitis "VEDI-UC”
Miasta: Białystok, Gdańsk, Katowice, Lublin i 6 innych miastWiek: do 17.99 latSponsor: Instytut Pomnik Centrum Zdrowia Dziecka
RekrutujeFaza III
MAGIC AML - Multiarm, Multicenter, RAndomized, Molecularly-GuIded Controlled Trial of Personalized Treatment Strategy - of Acute Myeloid Leukemia
Miasta: Białystok, Brzozów, Bydgoszcz, Chorzów i 12 innych miastWiek: od 18 latSponsor: Medical University Of Lodz
RekrutujeFaza III
Use of oral colchicine to determine restenosis in the superficial femoral artery - the COLSTENT study
Miasta: Białystok, Bydgoszcz, Chrzanów, Katowice i 4 inne miastaWiek: od 18 latSponsor: Uniwersytecki Szpital Kliniczny W Opolu
RekrutujeFaza III
AVO-CLL: a phase III multicenter, randomized, open-label, clinical trial comparing efficacy and safety of acalabrutinib in combination with obinutuzumab versus venetoclax in…
Miasta: Białystok, Gdańsk, Legnica, Warszawa i 3 inne miastaWiek: od 18 latSponsor: Specjalistyczny Szpital Im. Dra Alfreda Sokolowskiego
RekrutujeFaza III
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Miasta: Białystok, Bydgoszcz, Lublin, Peremyshl i 5 innych miastWiek: od 18 latSponsor: Janssen Cilag International
RekrutujeFaza III
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC)…
Miasta: Białystok, Gdańsk, Kraków, Lublin i 6 innych miastWiek: od 18 latSponsor: Merck Sharp & Dohme LLC
RekrutujeFaza III/IV
Optimal Medical Treatment of Difficult-to-treat Hypertension
Miasta: Białystok, Gdańsk, Gniewkowo, Grudziądz i 15 innych miastWiek: od 18 latSponsor: Narodowy Instytut Kardiologii Stefana Kardynala…
RekrutujeFaza III
A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis
Miasta: Białystok, Brodnica, Miechów, Nakło nad Notecią i 9 innych miastWiek: od 18 latSponsor: Genexine Inc.
RekrutujeFaza II/III
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Miasta: Białystok, Gdańsk, Poznań, SiedlceWiek: od 18 latSponsor: Daiichi Sankyo Inc.
RekrutujeFaza III
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Miasta: Białystok, Olsztyn, Poznań, WarszawaWiek: od 18 latSponsor: Shanghai Junshi Biosciences Co. Ltd.
RekrutujeFaza III
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid…
Miasta: Białystok, Kraków, Lublin, Oświęcim i 6 innych miastWiek: od 18 latSponsor: Colorado Prevention Center
RekrutujeFaza II
Clinical Trials Evaluating the Effect of Metformin Treatment on Function Endometrium in Women Diagnosed With Idiopathic Infertility
Miasta: BiałystokWiek: 18-64 latSponsor: Medical University Of Bialystok
RekrutujeFaza III
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Miasta: Białystok, Częstochowa, Katowice, Kluczbork i 10 innych miastWiek: od 18 latSponsor: Colorado Prevention Center
RekrutujeFaza III
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced…
Miasta: Białystok, Bystra, Gdynia, Gliwice i 9 innych miastWiek: od 18 latSponsor: Amgen Inc.